Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
10/30/2008 | CA2684240A1 Tetrahydroindole and tetrahydroindazole derivatives |
10/30/2008 | CA2683111A1 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists |
10/30/2008 | CA2682994A1 Heterocyclic compounds with affinity to muscarinic receptors |
10/30/2008 | CA2682676A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5 |
10/30/2008 | CA2682668A1 Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists |
10/30/2008 | CA2682539A1 Compounds comprising a cyclobutoxy group |
10/30/2008 | CA2682506A1 Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists |
10/30/2008 | CA2682356A1 7-substituted indole mcl-1 inhibitors |
10/30/2008 | CA2681779A1 Heterocyclic hydrazide compound and pesticidal use of the same |
10/30/2008 | CA2678639A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
10/29/2008 | EP1985612A1 Arymethylen substituted N-Acyl-gamma-aminoalcohols |
10/29/2008 | EP1984354A1 Pesticides containing a bicyclic bisamide structure |
10/29/2008 | EP1984353A1 Aurora kinase modulators and method of use |
10/29/2008 | EP1984352A1 A novel process for preparation of aripiprazole and its intermediates |
10/29/2008 | EP1984351A1 Compounds having 5-ht6 receptor affinity |
10/29/2008 | EP1984350A1 Pyrimidine derivatives used as pi-3 kinase inhibitors |
10/29/2008 | EP1984349A1 Piperidine derivatives as cxcr3 receptor antagonists |
10/29/2008 | EP1984340A1 Anthranilamide/2-amino-heteroarene carboxamide derivatives |
10/29/2008 | EP1984338A2 Pyridylphenyl compounds for inflammation and immune-related uses |
10/29/2008 | EP1984334A2 Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
10/29/2008 | EP1984332A2 Methods for treating hepatitis c |
10/29/2008 | EP1984331A1 Pyrrolidine derivatives as erk inhibitors |
10/29/2008 | EP1984330A1 Chemical compounds |
10/29/2008 | EP1983987A2 Dihydrodiazepines useful as inhibitors of protein kinases |
10/29/2008 | EP1983830A1 Methods to use 3-pyridyl derivatives as pesticides |
10/29/2008 | EP1891038B1 Substituted n-arylpyrrolidines as selective androgen receptor modulators |
10/29/2008 | EP1863795B1 Substituted triazole derivatives as oxytocin antagonists |
10/29/2008 | EP1751105B1 Piperazine derivatives of alkyl oxindoles |
10/29/2008 | EP1664016B1 Therapeutic agents useful for treating pain |
10/29/2008 | EP1641758B1 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
10/29/2008 | EP1556055B1 Cyclic nucleotide phosphodiesterase inhibitors having a benzodiazepine structure and their use in therapy |
10/29/2008 | EP1531811B1 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer |
10/29/2008 | EP1216228B1 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa |
10/29/2008 | CN101296922A Kinase inhibitors |
10/29/2008 | CN101296921A S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same |
10/29/2008 | CN101296920A Functionally selective alpha2C adrenoreceptor agonists |
10/29/2008 | CN101296914A Derivative having PPAR agonistic activity |
10/29/2008 | CN101296911A Arylurea derivatives as modulators of chemokine receptor activity |
10/29/2008 | CN101296910A Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase |
10/29/2008 | CN101296909A Pyrazine derivatives and use as pI3K inhibitors |
10/29/2008 | CN101296904A Amide derivatives as kinase inhibitors |
10/29/2008 | CN101296903A Novel indole-containing beta agonists, method for producing them and their use as drugs |
10/29/2008 | CN101293867A Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
10/29/2008 | CN100429201C Heterocyclic compounds and methods of use thereof |
10/28/2008 | USRE40558 Peroxisome proliferator-activated receptors agonists/ antagonists; 2-methyl-6-[3-(quinolin-2-ylmethoxy)-propoxymethyl]-benzoic acid; eating diorders; physiological detrimental blood level of insulin, glucose, free fatty acids, or triglycerides; hyperlipemia; atherosclerosis; antidiabetic agent |
10/28/2008 | US7442805 Substituted sulfonamide-indoles |
10/28/2008 | US7442802 e.g. 1-(1-cyclohexyl-5-(4-(methylsulfonyl)phenyl)pyrazol-3-yl)-4-hydroxybutan-1-one; antiinflammatory agent, analgesic, antipyretic, wound healing agents; gastrointestinal disorders; side effect reduction |
10/28/2008 | US7442799 reacting succinic acid derivatives with substituted hydrazines in presence of acid scavengers and solvents, to form chemical intermediates for benzoxazinones; cyclization |
10/28/2008 | US7442797 Platinum complex and light emitting device |
10/28/2008 | US7442795 Triazole compounds useful in therapy |
10/28/2008 | US7442713 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
10/28/2008 | US7442711 Amelioration of the development of cataracts and other ophthalmic diseases |
10/28/2008 | US7442710 Substituted phenyl methanones |
10/28/2008 | US7442704 Amide derivatives |
10/28/2008 | US7442703 Piperidine derivatives useful as CCR5 antagonists |
10/28/2008 | US7442702 Prostaglandin agonists |
10/28/2008 | US7442701 Amino-heterocycles as VR-1 antagonists for treating pain |
10/28/2008 | US7442699 For treatment of rheumatoid arthritis, inflammatory or autoimmune condition, viral infection, cancer; 4-{[4-(4-chlorophenyl)pyrimidin-2-yl]amino}benzamide |
10/28/2008 | US7442698 Substituted heterocyclic compounds and methods of use |
10/28/2008 | US7442693 Diazepine compounds as ligands of the melanocortin 1 and/or 4 receptors |
10/28/2008 | US7442447 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes |
10/28/2008 | CA2442227C Ccr5 antagonists useful for treating aids |
10/28/2008 | CA2403152C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
10/28/2008 | CA2353956C Remedial agent for erectile dysfunction |
10/28/2008 | CA2342102C Tan-1057 derivatives |
10/28/2008 | CA2283507C Process for preparing pyrazole derivatives |
10/23/2008 | WO2008127728A1 Biaryl compositions and methods for modulating a kinase cascade |
10/23/2008 | WO2008126933A2 Process for producing pesticidal benzamide compounds |
10/23/2008 | WO2008126899A1 5-membered heterocyclic derivative and use thereof for medical purposes |
10/23/2008 | WO2008126898A1 (aza)indole derivative and use thereof for medical purposes |
10/23/2008 | WO2008126890A1 Hydrazide compound and harmful arthropod-controlling agent containing the same |
10/23/2008 | WO2008126889A1 Hydrazide compound and harmful arthropod-controlling agent containing the same |
10/23/2008 | WO2008126886A1 Indole or indoline derivative |
10/23/2008 | WO2008126858A1 Method for producing amide compound |
10/23/2008 | WO2008126772A1 Therapeutic agent for hypertension |
10/23/2008 | WO2008126384A1 Method for producing quinolone carboxylic acid derivative |
10/23/2008 | WO2008125839A2 Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase |
10/23/2008 | WO2008125835A1 2-morpholin-4-yl-pyrimidines as pi3k inhibitors |
10/23/2008 | WO2008125833A1 Pharmaceutical compounds |
10/23/2008 | WO2008125691A2 Ethers of naphtalene carboxylic acid amides as cancer cure |
10/23/2008 | WO2008125627A1 Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonisis |
10/23/2008 | WO2008125570A1 New bradykinin b1 antagonists |
10/23/2008 | WO2008125342A2 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals |
10/23/2008 | WO2008125296A1 Vanilloid receptor ligands and the use thereof for the production of pharmaceuticals |
10/23/2008 | WO2008125215A1 Bicyclic and heterobicyclic derivatives, processes for preparing them and their uses |
10/23/2008 | WO2008099210A3 Piperazine derivatives for treatment of ad and related conditions |
10/23/2008 | WO2008090357A3 N, n; -substituted piperazines binding to melanocortin receptor |
10/23/2008 | WO2008070350A9 Methods and compositions related to wrapping of dehydrons |
10/23/2008 | WO2008064218A3 Amido anti-viral compounds |
10/23/2008 | WO2008053341A3 Bridged bicyclic indazoles as cannabinoid receptor ligands |
10/23/2008 | WO2008022355A3 Methods and reagents for detecting phosphomonoester groups |
10/23/2008 | US20080262235 Method and Apparatus for Producing Oxidized Compound |
10/23/2008 | US20080262228 Therapy for central nervous system disorders; Alzheimer's disease; 5-fluoro-8-(4-(4-(6-methoxyquinolin-8-) piperazin-1-yl )piperidin-1-yl)quinoline |
10/23/2008 | US20080262226 Methods of making compounds having a beta-adrenergic inhibitor and a linker and methods of making compounds having a beta-adrenergic inhibitor, a linker and a phosphodiesterase inhibitor |
10/23/2008 | US20080262225 Manganese, titanium, iron, cobalt, nickel, or copper with ligand |
10/23/2008 | US20080262224 Method of Preparation of Benzofuran-2-Carboxylic Acid -Amide |
10/23/2008 | US20080262045 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12 |
10/23/2008 | US20080262043 free acid Form III; precipitating it from a mixture of ethyl acetate and water after the oxidation of 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]-1H-benzimidazole with peracetic acid; pantoprazole sodium and pantoprazole sodium sesquihydrate |
10/23/2008 | US20080262042 1-[5-(2-Fluoropyridin-3-yl)-1-(phenylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine or a salt thereof; acid secretion inhibitor; potassium-competitive acid blocker |
10/23/2008 | US20080262041 Beta-Lactams for Treatment of Cns Disorders |